Bausch Health Companies Inc. (BHC) News

Bausch Health Companies Inc. (BHC): $5.81

1.76 (-23.25%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Filter BHC News Items

BHC News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BHC News Highlights

  • For BHC, its 30 day story count is now at 9.
  • Over the past 17 days, the trend for BHC's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • CNTB, EPD and ING are the most mentioned tickers in articles about BHC.

Latest BHC News From Around the Web

Below are the latest news stories about BAUSCH HEALTH COMPANIES INC that investors may wish to consider to help them evaluate BHC as an investment opportunity.

Bausch Health (BHC) Ulcerative Colitis Drug Meets Primary Goal

Bausch's (BHC) amiselimod achieves the primary and key secondary endpoints, including clinical and endoscopic measures, in the double-blind period of a phase II study.

Yahoo | December 22, 2023

Bausch Health Announces Positive Topline Results From Global Phase 2 Study Evaluating Amiselimod (an S1P antagonist) to Treat Ulcerative Colitis

Trial Meets Both Primary and Key Secondary Endpoints LAVAL, QC / ACCESSWIRE / December 21, 2023 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company") today announced positive topline results from the Company's Phase ...

Yahoo | December 21, 2023

Are Medical Stocks Lagging Bausch Health (BHC) This Year?

Here is how Bausch Health (BHC) and Connect Biopharma Holdings Limited Sponsored ADR (CNTB) have performed compared to their sector so far this year.

Yahoo | December 18, 2023

DUOBRII(TM) Lotion to Treat Moderate to Severe Plaque Psoriasis Now Available Through Quebec’s Public Drug Plan

LAVAL, QC / ACCESSWIRE / December 18, 2023 / Bausch Health, Canada, part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), ("Bausch Health" or the "Company") today announced that DUOBRII™ (0.01% w/w halobetasol propionate and 0.045% w/w tazarotene), ...

Yahoo | December 18, 2023

Implied Volatility Surging for On Bausch Health Companies (BHC) Stock Options

Investors need to pay close attention to Bausch Health Companies (BHC) stock based on the movements in the options market lately.

Yahoo | December 13, 2023

UnitedHealth (UNH) Unit Awarded a Medicaid Contract by AHCCCS

UnitedHealth Group's (UNH) unit has been picked up by AHCCCS to serve members of the ALTCS EPD program, which will serve as a means to further expand the health insurer's statewide footprint.

Yahoo | December 11, 2023

Wall Street Analysts Think Bausch (BHC) Could Surge 30.14%: Read This Before Placing a Bet

The mean of analysts' price targets for Bausch (BHC) points to a 30.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Yahoo | December 11, 2023

Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day

BRIDGEWATER, NJ / ACCESSWIRE / December 5, 2023 / Salix Pharmaceuticals, the gastroenterology division of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), The U.S. Pain Foundation (USPF), and The International Foundation for Gastrointestinal Disorders ...

Yahoo | December 5, 2023

Humana (HUM) Extends CINQCARE's Home Care Model to MA Members

Humana (HUM) teams up with CINQCARE to offer better health outcomes for its Medicare Advantage members of New York.

Yahoo | December 1, 2023

Is Bausch Health (BHC) Stock Outpacing Its Medical Peers This Year?

Here is how Bausch Health (BHC) and Gracell Biotechnologies Inc. Sponsored ADR (GRCL) have performed compared to their sector so far this year.

Yahoo | November 30, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!